chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 2.0
Sex: F
Vaccine: DTPPVHBHPB, FLU4, HEPA, MMR, PNC15, VARCEL
Symptoms: Influenza virus test negative, Intensive care, Laboratory test normal, Mental status changes, Nothing by mouth order
Clinical narrative: Patient overdue for multiple immunizations. Above vaccines due per state registry - given 10/10/2023. Patient with witness approximately 10-minute generalized tonic-clonic seizure on 10/11/2023. EMS call and IM Versed was given.  Upon arrival to emergency department, patient post-ictal. Repeat generalized tonic-clonic seizure activity approximately 15 minutes after resolution of first seizure. Patient febrile upon arrival to 38.4. In ED, Patient was given a total of 4 mg of Ativan (1mg of which was IM and the rest were 1 mg doses IV), Keppra load with 50 mg/kg, and fosphenytoin load of 20pe/kg which ultimately stopped the seizure activity after about 42 minutes.  Patient also received suppository Tylenol and IV Toradol.  She was given 2 normal saline boluses. Patient was admitted to ICU for ongoing management and remains admitted at this time.  Initially NPO on maintenance IV fluids as patient obtunded following multiple AED's. Supplemental oxygen placed - no advanced airway needed. She was weaned to RA overnight 10/11. Diet was advanced as mental status improved and she is tolerating PO intake. Off of IVF. Remains in ICU for observation.
Age: 2.0
Sex: F
Vaccine: DTPPVHBHPB, FLU4, HEPA, MMR, PNC15, VARCEL
Symptoms: Postictal state, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Patient overdue for multiple immunizations. Above vaccines due per state registry - given 10/10/2023. Patient with witness approximately 10-minute generalized tonic-clonic seizure on 10/11/2023. EMS call and IM Versed was given.  Upon arrival to emergency department, patient post-ictal. Repeat generalized tonic-clonic seizure activity approximately 15 minutes after resolution of first seizure. Patient febrile upon arrival to 38.4. In ED, Patient was given a total of 4 mg of Ativan (1mg of which was IM and the rest were 1 mg doses IV), Keppra load with 50 mg/kg, and fosphenytoin load of 20pe/kg which ultimately stopped the seizure activity after about 42 minutes.  Patient also received suppository Tylenol and IV Toradol.  She was given 2 normal saline boluses. Patient was admitted to ICU for ongoing management and remains admitted at this time.  Initially NPO on maintenance IV fluids as patient obtunded following multiple AED's. Supplemental oxygen placed - no advanced airway needed. She was weaned to RA overnight 10/11. Diet was advanced as mental status improved and she is tolerating PO intake. Off of IVF. Remains in ICU for observation.
Age: 22.0
Sex: M
Vaccine: FLUA4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Gave high dose flu shot instead of normal flu shot
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abdominal pain, Bicytopenia, Blood culture negative, COVID-19, Chemotherapy
Clinical narrative: Patient is a 64 y.o. male patient of MD with history of  Hodgkin's lymphoma on chemotherapy via right chest Mediport( follows with Dr.) with last chemotherapy two weeks back, coronary artery disease status post CABG, hypertension, dyslipidemia, obstructive sleep apnea on CPAP and obesity who presents to Hospital with fever.   Neutropenic fever, resolved Bicytopenia Patient with known hx of Hodgkin's lymphoma s/p recent chemotherapy two weeks back Presented with fever and chills ANC 460, Hgb 12-13 CT Chest and urinalysis negative Suspect source of fever is due to COVID Blood Cx x 2 with NGTD MRSA Probe negative Received neupogen x 1 ANC improved to 3000 ID followed Cultures remain negative at 48h, will stop empiric IV antibiotics now that neutropenia resolved   Covid-19 Virus Infection Date of onset of symptoms: 9/14/23 Symptoms present on admission: fever, chills, cough, adbominal pain and shortness of breath Date of covid positive test: 9/21/2023 Vaccination status: unvaccinated Imaging: CT chest with no pneumonia Oxygen requirements on admission: 2L Current oxygen requirements: RA Medical therapy: Received remdesivir while hospitalized Consultants following: ID Anticipated special isolation end date: 9/24/2023 Continue supportive care for COVID Non-Hodgkins Lymphoma Follows with Dr., currently on chemo with ABVD therapy   CAD s/p CABG Continue home statin and BB   Dyslipidemia On stain, continue   BPH On flomax, continue   OSA on CPAP Resume nightly   Obesity Body mass index is 32.96 kg/m².
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chills, Computerised tomogram thorax normal, Cough, Dyspnoea, Febrile neutropenia
Clinical narrative: Patient is a 64 y.o. male patient of MD with history of  Hodgkin's lymphoma on chemotherapy via right chest Mediport( follows with Dr.) with last chemotherapy two weeks back, coronary artery disease status post CABG, hypertension, dyslipidemia, obstructive sleep apnea on CPAP and obesity who presents to Hospital with fever.   Neutropenic fever, resolved Bicytopenia Patient with known hx of Hodgkin's lymphoma s/p recent chemotherapy two weeks back Presented with fever and chills ANC 460, Hgb 12-13 CT Chest and urinalysis negative Suspect source of fever is due to COVID Blood Cx x 2 with NGTD MRSA Probe negative Received neupogen x 1 ANC improved to 3000 ID followed Cultures remain negative at 48h, will stop empiric IV antibiotics now that neutropenia resolved   Covid-19 Virus Infection Date of onset of symptoms: 9/14/23 Symptoms present on admission: fever, chills, cough, adbominal pain and shortness of breath Date of covid positive test: 9/21/2023 Vaccination status: unvaccinated Imaging: CT chest with no pneumonia Oxygen requirements on admission: 2L Current oxygen requirements: RA Medical therapy: Received remdesivir while hospitalized Consultants following: ID Anticipated special isolation end date: 9/24/2023 Continue supportive care for COVID Non-Hodgkins Lymphoma Follows with Dr., currently on chemo with ABVD therapy   CAD s/p CABG Continue home statin and BB   Dyslipidemia On stain, continue   BPH On flomax, continue   OSA on CPAP Resume nightly   Obesity Body mass index is 32.96 kg/m².
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Haemoglobin, Neutrophil count decreased, Pyrexia, SARS-CoV-2 test positive, Staphylococcus test negative
Clinical narrative: Patient is a 64 y.o. male patient of MD with history of  Hodgkin's lymphoma on chemotherapy via right chest Mediport( follows with Dr.) with last chemotherapy two weeks back, coronary artery disease status post CABG, hypertension, dyslipidemia, obstructive sleep apnea on CPAP and obesity who presents to Hospital with fever.   Neutropenic fever, resolved Bicytopenia Patient with known hx of Hodgkin's lymphoma s/p recent chemotherapy two weeks back Presented with fever and chills ANC 460, Hgb 12-13 CT Chest and urinalysis negative Suspect source of fever is due to COVID Blood Cx x 2 with NGTD MRSA Probe negative Received neupogen x 1 ANC improved to 3000 ID followed Cultures remain negative at 48h, will stop empiric IV antibiotics now that neutropenia resolved   Covid-19 Virus Infection Date of onset of symptoms: 9/14/23 Symptoms present on admission: fever, chills, cough, adbominal pain and shortness of breath Date of covid positive test: 9/21/2023 Vaccination status: unvaccinated Imaging: CT chest with no pneumonia Oxygen requirements on admission: 2L Current oxygen requirements: RA Medical therapy: Received remdesivir while hospitalized Consultants following: ID Anticipated special isolation end date: 9/24/2023 Continue supportive care for COVID Non-Hodgkins Lymphoma Follows with Dr., currently on chemo with ABVD therapy   CAD s/p CABG Continue home statin and BB   Dyslipidemia On stain, continue   BPH On flomax, continue   OSA on CPAP Resume nightly   Obesity Body mass index is 32.96 kg/m².
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Urine analysis normal
Clinical narrative: Patient is a 64 y.o. male patient of MD with history of  Hodgkin's lymphoma on chemotherapy via right chest Mediport( follows with Dr.) with last chemotherapy two weeks back, coronary artery disease status post CABG, hypertension, dyslipidemia, obstructive sleep apnea on CPAP and obesity who presents to Hospital with fever.   Neutropenic fever, resolved Bicytopenia Patient with known hx of Hodgkin's lymphoma s/p recent chemotherapy two weeks back Presented with fever and chills ANC 460, Hgb 12-13 CT Chest and urinalysis negative Suspect source of fever is due to COVID Blood Cx x 2 with NGTD MRSA Probe negative Received neupogen x 1 ANC improved to 3000 ID followed Cultures remain negative at 48h, will stop empiric IV antibiotics now that neutropenia resolved   Covid-19 Virus Infection Date of onset of symptoms: 9/14/23 Symptoms present on admission: fever, chills, cough, adbominal pain and shortness of breath Date of covid positive test: 9/21/2023 Vaccination status: unvaccinated Imaging: CT chest with no pneumonia Oxygen requirements on admission: 2L Current oxygen requirements: RA Medical therapy: Received remdesivir while hospitalized Consultants following: ID Anticipated special isolation end date: 9/24/2023 Continue supportive care for COVID Non-Hodgkins Lymphoma Follows with Dr., currently on chemo with ABVD therapy   CAD s/p CABG Continue home statin and BB   Dyslipidemia On stain, continue   BPH On flomax, continue   OSA on CPAP Resume nightly   Obesity Body mass index is 32.96 kg/m².
Age: 46.0
Sex: F
Vaccine: FLU4
Symptoms: Urticaria
Clinical narrative: DEVELOPED SYSTEMIC HIVES ABOUT 12 HOURS AFTER VACCINE. SEEN AT ED ON 10/7/23 AND 10/8/23. STARTED ON ANTIBIOTICS, PREDNISONE, AND BENADRYL
Age: 5.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Fever, redness and swelling around administration site started one day after.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Asthenia, Blood creatinine, Breath sounds abnormal
Clinical narrative: Per admitting documentation: Pt with history noted above, presents with cough over last 7 days. Initially productive though has been dry cough for past 3-4 days. Yesterday, pt experienced debilitating fatigue, he went to take a nap and upon waking, was so weak he was unable to get up out of bed, thus calling EMS, prompting presentation today. States this weakness developed yesterday but was fine before. No fever or chills, chest pain. Does admit to leg swelling which he states is new for him.      Clinical Summary Patient was admitted to MedSurg for further management of COVID-19 pneumonia with acute hypoxic respiratory failure.  He was started on Decadron and remdesivir.  E consult for infectious disease was obtained, recommended continue remdesivir x5 days and Decadron x10 days.  Patient was placed on scheduled albuterol HFA.  On admission he had some mild volume overload secondary to acute on chronic HFrEF and received 2 doses of IV Lasix with significant improvement.  His oxygen requirements continue to improve throughout his hospital stay and at the time of discharge he was found to not require any oxygen on 6-minute hall walk test.  His lungs sound improved throughout his hospital stay and he had no active wheezing at the time of discharge.  Patient continued to have significant generalized weakness.  Physical therapy was consulted and worked with patient throughout his hospital stay and at the time of discharge she was near his baseline.  He did decline discharged to SNF.  Care management was consulted for assistance with discharge planning.  Patient was discharged home on 9/28 in stable condition.  He had completed 5 days of remdesivir.  He is continued on Decadron to complete a total of 10 days.  Patient's renal function had returned to baseline.  He is instructed to follow-up with his primary care provider within the next 7 days.   Discharge diagnosis COVID 19 pneumonia - resolved, completed remdesivir, DC on decadron to complete 10 days  AECOPD -resolved  Acute on chronic HFrEF - resolved  AKI on CKD IIIb - resolved, Cr at baseline Essential hypertension History of CAD MDD Generalized weakness Deconditioning
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cardiac failure acute, Chronic obstructive pulmonary disease, Condition aggravated, Cough
Clinical narrative: Per admitting documentation: Pt with history noted above, presents with cough over last 7 days. Initially productive though has been dry cough for past 3-4 days. Yesterday, pt experienced debilitating fatigue, he went to take a nap and upon waking, was so weak he was unable to get up out of bed, thus calling EMS, prompting presentation today. States this weakness developed yesterday but was fine before. No fever or chills, chest pain. Does admit to leg swelling which he states is new for him.      Clinical Summary Patient was admitted to MedSurg for further management of COVID-19 pneumonia with acute hypoxic respiratory failure.  He was started on Decadron and remdesivir.  E consult for infectious disease was obtained, recommended continue remdesivir x5 days and Decadron x10 days.  Patient was placed on scheduled albuterol HFA.  On admission he had some mild volume overload secondary to acute on chronic HFrEF and received 2 doses of IV Lasix with significant improvement.  His oxygen requirements continue to improve throughout his hospital stay and at the time of discharge he was found to not require any oxygen on 6-minute hall walk test.  His lungs sound improved throughout his hospital stay and he had no active wheezing at the time of discharge.  Patient continued to have significant generalized weakness.  Physical therapy was consulted and worked with patient throughout his hospital stay and at the time of discharge she was near his baseline.  He did decline discharged to SNF.  Care management was consulted for assistance with discharge planning.  Patient was discharged home on 9/28 in stable condition.  He had completed 5 days of remdesivir.  He is continued on Decadron to complete a total of 10 days.  Patient's renal function had returned to baseline.  He is instructed to follow-up with his primary care provider within the next 7 days.   Discharge diagnosis COVID 19 pneumonia - resolved, completed remdesivir, DC on decadron to complete 10 days  AECOPD -resolved  Acute on chronic HFrEF - resolved  AKI on CKD IIIb - resolved, Cr at baseline Essential hypertension History of CAD MDD Generalized weakness Deconditioning
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypervolaemia, Left ventricular failure, Mobility decreased, Peripheral swelling
Clinical narrative: Per admitting documentation: Pt with history noted above, presents with cough over last 7 days. Initially productive though has been dry cough for past 3-4 days. Yesterday, pt experienced debilitating fatigue, he went to take a nap and upon waking, was so weak he was unable to get up out of bed, thus calling EMS, prompting presentation today. States this weakness developed yesterday but was fine before. No fever or chills, chest pain. Does admit to leg swelling which he states is new for him.      Clinical Summary Patient was admitted to MedSurg for further management of COVID-19 pneumonia with acute hypoxic respiratory failure.  He was started on Decadron and remdesivir.  E consult for infectious disease was obtained, recommended continue remdesivir x5 days and Decadron x10 days.  Patient was placed on scheduled albuterol HFA.  On admission he had some mild volume overload secondary to acute on chronic HFrEF and received 2 doses of IV Lasix with significant improvement.  His oxygen requirements continue to improve throughout his hospital stay and at the time of discharge he was found to not require any oxygen on 6-minute hall walk test.  His lungs sound improved throughout his hospital stay and he had no active wheezing at the time of discharge.  Patient continued to have significant generalized weakness.  Physical therapy was consulted and worked with patient throughout his hospital stay and at the time of discharge she was near his baseline.  He did decline discharged to SNF.  Care management was consulted for assistance with discharge planning.  Patient was discharged home on 9/28 in stable condition.  He had completed 5 days of remdesivir.  He is continued on Decadron to complete a total of 10 days.  Patient's renal function had returned to baseline.  He is instructed to follow-up with his primary care provider within the next 7 days.   Discharge diagnosis COVID 19 pneumonia - resolved, completed remdesivir, DC on decadron to complete 10 days  AECOPD -resolved  Acute on chronic HFrEF - resolved  AKI on CKD IIIb - resolved, Cr at baseline Essential hypertension History of CAD MDD Generalized weakness Deconditioning
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Productive cough, Renal impairment, Walking distance test normal
Clinical narrative: Per admitting documentation: Pt with history noted above, presents with cough over last 7 days. Initially productive though has been dry cough for past 3-4 days. Yesterday, pt experienced debilitating fatigue, he went to take a nap and upon waking, was so weak he was unable to get up out of bed, thus calling EMS, prompting presentation today. States this weakness developed yesterday but was fine before. No fever or chills, chest pain. Does admit to leg swelling which he states is new for him.      Clinical Summary Patient was admitted to MedSurg for further management of COVID-19 pneumonia with acute hypoxic respiratory failure.  He was started on Decadron and remdesivir.  E consult for infectious disease was obtained, recommended continue remdesivir x5 days and Decadron x10 days.  Patient was placed on scheduled albuterol HFA.  On admission he had some mild volume overload secondary to acute on chronic HFrEF and received 2 doses of IV Lasix with significant improvement.  His oxygen requirements continue to improve throughout his hospital stay and at the time of discharge he was found to not require any oxygen on 6-minute hall walk test.  His lungs sound improved throughout his hospital stay and he had no active wheezing at the time of discharge.  Patient continued to have significant generalized weakness.  Physical therapy was consulted and worked with patient throughout his hospital stay and at the time of discharge she was near his baseline.  He did decline discharged to SNF.  Care management was consulted for assistance with discharge planning.  Patient was discharged home on 9/28 in stable condition.  He had completed 5 days of remdesivir.  He is continued on Decadron to complete a total of 10 days.  Patient's renal function had returned to baseline.  He is instructed to follow-up with his primary care provider within the next 7 days.   Discharge diagnosis COVID 19 pneumonia - resolved, completed remdesivir, DC on decadron to complete 10 days  AECOPD -resolved  Acute on chronic HFrEF - resolved  AKI on CKD IIIb - resolved, Cr at baseline Essential hypertension History of CAD MDD Generalized weakness Deconditioning
Age: 57.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: High dose influenza vaccine administered instead of Fluzone Quad.
Age: 46.0
Sex: F
Vaccine: FLUA4
Symptoms: Injection site reaction, Pain, Pain in extremity, Product administered at inappropriate site
Clinical narrative: When getting the injection I could actually feel the liquid from the medication going into my shoulder area and I then felt like the vaccine was given too high on the arm.  My arm was sore that night (like expected) but now 1.5 weeks later, it still hurts when I move my arm certain ways (raising my arm).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with 2 boosters
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Vomiting
Clinical narrative: Severe dizziness, severe vomiting, diarrhea for about one hour.  Then slept until 2:00am. Woke up and felt OK.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Injection site haematoma, Injection site pain
Clinical narrative: ERYTHEMA, HEMATOMA AROUND INJECTION SITE, PAIN
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Alcohol test negative, Blood test, Cold sweat, Computerised tomogram normal, Confusional state
Clinical narrative: Seizure-like episodes - absent seizure followed by severe headache, confusion, excessive salivation, heart rate drop to 36 BPM, cold sweat, instability, extreme fatigue. 3 total episodes in 24 hours. Patient was taken to the ER where he received bloodwork, urine test, and a CT scan. Discharged with a referral to neurology.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Drug screen negative, Fatigue, Gait disturbance, Headache, Heart rate decreased
Clinical narrative: Seizure-like episodes - absent seizure followed by severe headache, confusion, excessive salivation, heart rate drop to 36 BPM, cold sweat, instability, extreme fatigue. 3 total episodes in 24 hours. Patient was taken to the ER where he received bloodwork, urine test, and a CT scan. Discharged with a referral to neurology.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Salivary hypersecretion, Seizure like phenomena, Urine analysis
Clinical narrative: Seizure-like episodes - absent seizure followed by severe headache, confusion, excessive salivation, heart rate drop to 36 BPM, cold sweat, instability, extreme fatigue. 3 total episodes in 24 hours. Patient was taken to the ER where he received bloodwork, urine test, and a CT scan. Discharged with a referral to neurology.
Age: 53.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: High dose flu vaccine administered instead of Fluzone Quad.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Chills, Decreased appetite, Headache, Injection site erythema
Clinical narrative: Injection site red , swollen, hard, painful. Swollen and painful glands R upper arm to R underarm and along R side of chest. Throbbing headache , using gloves, extra layers of clothing and blankets for episodes of chills and weakness, loss of appetite.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site induration, Injection site pain, Injection site swelling, Lymph node pain, Lymphadenopathy
Clinical narrative: Injection site red , swollen, hard, painful. Swollen and painful glands R upper arm to R underarm and along R side of chest. Throbbing headache , using gloves, extra layers of clothing and blankets for episodes of chills and weakness, loss of appetite.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain
Clinical narrative: Experiencing body aches and extreme fatigue for 24 hours, headache occurred at 36 hours.  Body aches ,fatigue, and headache ongoing at this time. Self treating with bed rest and ibuprofen.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest pain
Clinical narrative: I have been having severe burning in my chest. It has never happen before. I went to the er sometime in March 2023. They did some blood test.
Age: 54.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Abdominal pain, Diarrhoea, Nausea, Palpitations, Pyrexia
Clinical narrative: Due to concern by patient over significant side effects of a 2nd Shingrix vaccine on 9/25/23 and concern if received correct vaccine, a review and reporting were done.  Reviewed vaccine/diluent - lot, exp, NDC, shipment of corresponding lot/NDC/expiration date, spoke with MA who administered, reviewed documentation, reviewed accompanying Shingrix Prescribing Information insert.   Called GlaxoSmithKline to report suspected adverse reactions- Reported all patient signs and symptoms patient had reported since experiencing after 2nd vaccine These include - Nausea/Vomiting, Heart racing, shaking, fever, abdominal pain, diarrhea. Pt hit head during vomiting episode - thinks may have passed out -headache. Reported "hearing things, babbling nonsense" Increased liver enzymes.   Reviewed particular lot 2TL27 - GSK reporting no issues/recalls.   Advised that the following s/s are known reported SE of Shingrix - Gi issues - N/V, abd pain, diarrhea; HA; fever; shaking.  All other s/s have not been reported in clinical trials.   Conclusion: Pt's s/s  fortunately seem to be resolving per notes. Patient was given correct vaccine/diluent. No administrator errors in reconstitution or administering vaccine found.  Pt having s/s from Shingrix that are known s/s with this vaccine. Other signs/symptoms not seen in clinical trials have been reported to GSK.
Age: 54.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Tremor, Vomiting
Clinical narrative: Due to concern by patient over significant side effects of a 2nd Shingrix vaccine on 9/25/23 and concern if received correct vaccine, a review and reporting were done.  Reviewed vaccine/diluent - lot, exp, NDC, shipment of corresponding lot/NDC/expiration date, spoke with MA who administered, reviewed documentation, reviewed accompanying Shingrix Prescribing Information insert.   Called GlaxoSmithKline to report suspected adverse reactions- Reported all patient signs and symptoms patient had reported since experiencing after 2nd vaccine These include - Nausea/Vomiting, Heart racing, shaking, fever, abdominal pain, diarrhea. Pt hit head during vomiting episode - thinks may have passed out -headache. Reported "hearing things, babbling nonsense" Increased liver enzymes.   Reviewed particular lot 2TL27 - GSK reporting no issues/recalls.   Advised that the following s/s are known reported SE of Shingrix - Gi issues - N/V, abd pain, diarrhea; HA; fever; shaking.  All other s/s have not been reported in clinical trials.   Conclusion: Pt's s/s  fortunately seem to be resolving per notes. Patient was given correct vaccine/diluent. No administrator errors in reconstitution or administering vaccine found.  Pt having s/s from Shingrix that are known s/s with this vaccine. Other signs/symptoms not seen in clinical trials have been reported to GSK.
Age: 54.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Computerised tomogram head normal, Fall, Head discomfort, Head injury, Headache
Clinical narrative: Due to concern by patient over significant side effects of a 2nd Shingrix vaccine on 9/25/23 and concern if received correct vaccine, a review and reporting were done.  Reviewed vaccine/diluent - lot, exp, NDC, shipment of corresponding lot/NDC/expiration date, spoke with MA who administered, reviewed documentation, reviewed accompanying Shingrix Prescribing Information insert.   Called GlaxoSmithKline to report suspected adverse reactions- Reported all patient signs and symptoms patient had reported since experiencing after 2nd vaccine These include - Nausea/Vomiting, Heart racing, shaking, fever, abdominal pain, diarrhea. Pt hit head during vomiting episode - thinks may have passed out -headache. Reported "hearing things, babbling nonsense" Increased liver enzymes.   Reviewed particular lot 2TL27 - GSK reporting no issues/recalls.   Advised that the following s/s are known reported SE of Shingrix - Gi issues - N/V, abd pain, diarrhea; HA; fever; shaking.  All other s/s have not been reported in clinical trials.   Conclusion: Pt's s/s  fortunately seem to be resolving per notes. Patient was given correct vaccine/diluent. No administrator errors in reconstitution or administering vaccine found.  Pt having s/s from Shingrix that are known s/s with this vaccine. Other signs/symptoms not seen in clinical trials have been reported to GSK.
Age: 54.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Loss of consciousness, Nausea, Sleep disorder, Syncope, Vomiting
Clinical narrative: Due to concern by patient over significant side effects of a 2nd Shingrix vaccine on 9/25/23 and concern if received correct vaccine, a review and reporting were done.  Reviewed vaccine/diluent - lot, exp, NDC, shipment of corresponding lot/NDC/expiration date, spoke with MA who administered, reviewed documentation, reviewed accompanying Shingrix Prescribing Information insert.   Called GlaxoSmithKline to report suspected adverse reactions- Reported all patient signs and symptoms patient had reported since experiencing after 2nd vaccine These include - Nausea/Vomiting, Heart racing, shaking, fever, abdominal pain, diarrhea. Pt hit head during vomiting episode - thinks may have passed out -headache. Reported "hearing things, babbling nonsense" Increased liver enzymes.   Reviewed particular lot 2TL27 - GSK reporting no issues/recalls.   Advised that the following s/s are known reported SE of Shingrix - Gi issues - N/V, abd pain, diarrhea; HA; fever; shaking.  All other s/s have not been reported in clinical trials.   Conclusion: Pt's s/s  fortunately seem to be resolving per notes. Patient was given correct vaccine/diluent. No administrator errors in reconstitution or administering vaccine found.  Pt having s/s from Shingrix that are known s/s with this vaccine. Other signs/symptoms not seen in clinical trials have been reported to GSK.
Age: 1.33
Sex: M
Vaccine: MMR
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: The original order was for a MMR and Varicella (2 separate injections if it is their first time receiving). Staff gave MMR and MMRV. The evening (late nights), only has one MA on staff which negates the double sign-off to check to make sure the right vaccine is given to the patient.
Age: 27.0
Sex: M
Vaccine: HEP
Symptoms: Dizziness, Headache, Injection site pain, Nausea, Oropharyngeal pain
Clinical narrative: individual symptoms of adverse events began at 6AM 10.12.2023, symptoms to include dull headache, slight sore throat, dizzy and nausea, injection site right deltoid muscle sore. Individual will be resting at home, self care.
Age: 35.0
Sex: F
Vaccine: IPV
Symptoms: Wrong product administered
Clinical narrative: IPOL was given instead of tuberculosis
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered at inappropriate site
Clinical narrative: Vaccination was not given in deltoid muscle but was given about 4 inches below the muscle
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema
Clinical narrative: Vaccination was not given in deltoid muscle but was given about 4 inches below the muscle
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered at inappropriate site
Clinical narrative: Local redness over 5 inch, patient believes might also be due to vaccinating lower than deltoid muscle.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema
Clinical narrative: Local redness over 5 inch, patient believes might also be due to vaccinating lower than deltoid muscle.
Age: 7.0
Sex: F
Vaccine: TDAP
Symptoms: Expired product administered
Clinical narrative: Expired dose given
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Atrial fibrillation, COVID-19, Chest X-ray abnormal, Computerised tomogram head normal
Clinical narrative: Patient is a 81 y.o. female patient of MD with history of atrial fibrillation, hypertension, diabetes, hypothyroidism altered mentation presented to Hospital with  .   Hypoxemic respiratory failure.(Patient states she is on 2 L oxygen at home.) Covid-19 Virus Infection Date of onset of symptoms: Unknown Symptoms present on admission: Yes hypoxemia on 4 L oxygen. Date of covid positive test: 9/16/23 Vaccination status: Unknown- possibly Moderna x2 with last in 2021 Imaging: Chest x-ray 9/16 suspect very mild patchy infiltrate within the lower lungs. Oxygen requirements on admission: Yes 4 L Current oxygen requirements:2L NC Medical therapy: steroids- day 7, remdesivir- finished 5 day course 9/21 Consultants following: ID Anticipated special isolation end date: Unknown Patient with improvement in her respiratory status continue remdesivir and steroids Wean O2 as able-sounds like per nursing discussion with family patient was previously on 4 L nasal cannula for history of COPD but facility had been able to wean off oxygen. Finished Rocephin course    UTI Patient with dysuria  Urinalysis showing gram-negative bacilli?greater than 100,000 and E. coli which was pan susceptible Repeat UA ordered by ID. Nursing aware of need to collect Continue Rocephin per discussion with ID- completed course    Metabolic encephalopathy Patient awake, alert and oriented x3but with persistent hallucinations. Per nursing, during her discussion with family they mentioned that she gets hallucinations with UTIs.  Unknown baseline. CT head no acute abnormalities. Monitor. Atrial fibrillation Continue metoprolol, Eliquis as per home regimen. EKG per ED documentation sinus rhythm heart rate 62, abnormal ST-T segments and T waves. Troponin 35, 30. With negative delta    Diabetes On metformin at home Hold and initiate SSI.   Hypertension Continue metoprolol and losartan.   Hypothyroidism Resume levothyroxine.   Hypokalemia -resolved   GERD Pepcid   Patient seen and examined on day of discharge in full PPE.  Stable on 2 L nasal cannula.  States she has been having less pain with urination.  No fevers overnight.  Has finished off course of Rocephin.  Has patient off course of remdesivir.  Suspect white blood cell count likely in the setting of steroid use given no fevers, hypotension or tachycardia. Stable for discharge back to SNF on 2L NC
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Diabetes mellitus, Dysuria, Electrocardiogram ST-T segment abnormal, Gastroenteritis Escherichia coli, Gastrooesophageal reflux disease
Clinical narrative: Patient is a 81 y.o. female patient of MD with history of atrial fibrillation, hypertension, diabetes, hypothyroidism altered mentation presented to Hospital with  .   Hypoxemic respiratory failure.(Patient states she is on 2 L oxygen at home.) Covid-19 Virus Infection Date of onset of symptoms: Unknown Symptoms present on admission: Yes hypoxemia on 4 L oxygen. Date of covid positive test: 9/16/23 Vaccination status: Unknown- possibly Moderna x2 with last in 2021 Imaging: Chest x-ray 9/16 suspect very mild patchy infiltrate within the lower lungs. Oxygen requirements on admission: Yes 4 L Current oxygen requirements:2L NC Medical therapy: steroids- day 7, remdesivir- finished 5 day course 9/21 Consultants following: ID Anticipated special isolation end date: Unknown Patient with improvement in her respiratory status continue remdesivir and steroids Wean O2 as able-sounds like per nursing discussion with family patient was previously on 4 L nasal cannula for history of COPD but facility had been able to wean off oxygen. Finished Rocephin course    UTI Patient with dysuria  Urinalysis showing gram-negative bacilli?greater than 100,000 and E. coli which was pan susceptible Repeat UA ordered by ID. Nursing aware of need to collect Continue Rocephin per discussion with ID- completed course    Metabolic encephalopathy Patient awake, alert and oriented x3but with persistent hallucinations. Per nursing, during her discussion with family they mentioned that she gets hallucinations with UTIs.  Unknown baseline. CT head no acute abnormalities. Monitor. Atrial fibrillation Continue metoprolol, Eliquis as per home regimen. EKG per ED documentation sinus rhythm heart rate 62, abnormal ST-T segments and T waves. Troponin 35, 30. With negative delta    Diabetes On metformin at home Hold and initiate SSI.   Hypertension Continue metoprolol and losartan.   Hypothyroidism Resume levothyroxine.   Hypokalemia -resolved   GERD Pepcid   Patient seen and examined on day of discharge in full PPE.  Stable on 2 L nasal cannula.  States she has been having less pain with urination.  No fevers overnight.  Has finished off course of Rocephin.  Has patient off course of remdesivir.  Suspect white blood cell count likely in the setting of steroid use given no fevers, hypotension or tachycardia. Stable for discharge back to SNF on 2L NC
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hallucination, Hypertension, Hypokalaemia, Hypothyroidism, Hypoxia
Clinical narrative: Patient is a 81 y.o. female patient of MD with history of atrial fibrillation, hypertension, diabetes, hypothyroidism altered mentation presented to Hospital with  .   Hypoxemic respiratory failure.(Patient states she is on 2 L oxygen at home.) Covid-19 Virus Infection Date of onset of symptoms: Unknown Symptoms present on admission: Yes hypoxemia on 4 L oxygen. Date of covid positive test: 9/16/23 Vaccination status: Unknown- possibly Moderna x2 with last in 2021 Imaging: Chest x-ray 9/16 suspect very mild patchy infiltrate within the lower lungs. Oxygen requirements on admission: Yes 4 L Current oxygen requirements:2L NC Medical therapy: steroids- day 7, remdesivir- finished 5 day course 9/21 Consultants following: ID Anticipated special isolation end date: Unknown Patient with improvement in her respiratory status continue remdesivir and steroids Wean O2 as able-sounds like per nursing discussion with family patient was previously on 4 L nasal cannula for history of COPD but facility had been able to wean off oxygen. Finished Rocephin course    UTI Patient with dysuria  Urinalysis showing gram-negative bacilli?greater than 100,000 and E. coli which was pan susceptible Repeat UA ordered by ID. Nursing aware of need to collect Continue Rocephin per discussion with ID- completed course    Metabolic encephalopathy Patient awake, alert and oriented x3but with persistent hallucinations. Per nursing, during her discussion with family they mentioned that she gets hallucinations with UTIs.  Unknown baseline. CT head no acute abnormalities. Monitor. Atrial fibrillation Continue metoprolol, Eliquis as per home regimen. EKG per ED documentation sinus rhythm heart rate 62, abnormal ST-T segments and T waves. Troponin 35, 30. With negative delta    Diabetes On metformin at home Hold and initiate SSI.   Hypertension Continue metoprolol and losartan.   Hypothyroidism Resume levothyroxine.   Hypokalemia -resolved   GERD Pepcid   Patient seen and examined on day of discharge in full PPE.  Stable on 2 L nasal cannula.  States she has been having less pain with urination.  No fevers overnight.  Has finished off course of Rocephin.  Has patient off course of remdesivir.  Suspect white blood cell count likely in the setting of steroid use given no fevers, hypotension or tachycardia. Stable for discharge back to SNF on 2L NC
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Lung infiltration, Mental status changes, Metabolic encephalopathy, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient is a 81 y.o. female patient of MD with history of atrial fibrillation, hypertension, diabetes, hypothyroidism altered mentation presented to Hospital with  .   Hypoxemic respiratory failure.(Patient states she is on 2 L oxygen at home.) Covid-19 Virus Infection Date of onset of symptoms: Unknown Symptoms present on admission: Yes hypoxemia on 4 L oxygen. Date of covid positive test: 9/16/23 Vaccination status: Unknown- possibly Moderna x2 with last in 2021 Imaging: Chest x-ray 9/16 suspect very mild patchy infiltrate within the lower lungs. Oxygen requirements on admission: Yes 4 L Current oxygen requirements:2L NC Medical therapy: steroids- day 7, remdesivir- finished 5 day course 9/21 Consultants following: ID Anticipated special isolation end date: Unknown Patient with improvement in her respiratory status continue remdesivir and steroids Wean O2 as able-sounds like per nursing discussion with family patient was previously on 4 L nasal cannula for history of COPD but facility had been able to wean off oxygen. Finished Rocephin course    UTI Patient with dysuria  Urinalysis showing gram-negative bacilli?greater than 100,000 and E. coli which was pan susceptible Repeat UA ordered by ID. Nursing aware of need to collect Continue Rocephin per discussion with ID- completed course    Metabolic encephalopathy Patient awake, alert and oriented x3but with persistent hallucinations. Per nursing, during her discussion with family they mentioned that she gets hallucinations with UTIs.  Unknown baseline. CT head no acute abnormalities. Monitor. Atrial fibrillation Continue metoprolol, Eliquis as per home regimen. EKG per ED documentation sinus rhythm heart rate 62, abnormal ST-T segments and T waves. Troponin 35, 30. With negative delta    Diabetes On metformin at home Hold and initiate SSI.   Hypertension Continue metoprolol and losartan.   Hypothyroidism Resume levothyroxine.   Hypokalemia -resolved   GERD Pepcid   Patient seen and examined on day of discharge in full PPE.  Stable on 2 L nasal cannula.  States she has been having less pain with urination.  No fevers overnight.  Has finished off course of Rocephin.  Has patient off course of remdesivir.  Suspect white blood cell count likely in the setting of steroid use given no fevers, hypotension or tachycardia. Stable for discharge back to SNF on 2L NC
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin, Urinary tract infection, Urine analysis abnormal, White blood cell count
Clinical narrative: Patient is a 81 y.o. female patient of MD with history of atrial fibrillation, hypertension, diabetes, hypothyroidism altered mentation presented to Hospital with  .   Hypoxemic respiratory failure.(Patient states she is on 2 L oxygen at home.) Covid-19 Virus Infection Date of onset of symptoms: Unknown Symptoms present on admission: Yes hypoxemia on 4 L oxygen. Date of covid positive test: 9/16/23 Vaccination status: Unknown- possibly Moderna x2 with last in 2021 Imaging: Chest x-ray 9/16 suspect very mild patchy infiltrate within the lower lungs. Oxygen requirements on admission: Yes 4 L Current oxygen requirements:2L NC Medical therapy: steroids- day 7, remdesivir- finished 5 day course 9/21 Consultants following: ID Anticipated special isolation end date: Unknown Patient with improvement in her respiratory status continue remdesivir and steroids Wean O2 as able-sounds like per nursing discussion with family patient was previously on 4 L nasal cannula for history of COPD but facility had been able to wean off oxygen. Finished Rocephin course    UTI Patient with dysuria  Urinalysis showing gram-negative bacilli?greater than 100,000 and E. coli which was pan susceptible Repeat UA ordered by ID. Nursing aware of need to collect Continue Rocephin per discussion with ID- completed course    Metabolic encephalopathy Patient awake, alert and oriented x3but with persistent hallucinations. Per nursing, during her discussion with family they mentioned that she gets hallucinations with UTIs.  Unknown baseline. CT head no acute abnormalities. Monitor. Atrial fibrillation Continue metoprolol, Eliquis as per home regimen. EKG per ED documentation sinus rhythm heart rate 62, abnormal ST-T segments and T waves. Troponin 35, 30. With negative delta    Diabetes On metformin at home Hold and initiate SSI.   Hypertension Continue metoprolol and losartan.   Hypothyroidism Resume levothyroxine.   Hypokalemia -resolved   GERD Pepcid   Patient seen and examined on day of discharge in full PPE.  Stable on 2 L nasal cannula.  States she has been having less pain with urination.  No fevers overnight.  Has finished off course of Rocephin.  Has patient off course of remdesivir.  Suspect white blood cell count likely in the setting of steroid use given no fevers, hypotension or tachycardia. Stable for discharge back to SNF on 2L NC
Age: 1.25
Sex: M
Vaccine: HIBV, PNC13, TDAP
Symptoms: Injection site erythema, Injection site irritation
Clinical narrative: It was reported that the patient experienced redness and irritation around the injection site the day after administration.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Atrial fibrillation, Blood thyroid stimulating hormone normal, COVID-19, Computerised tomogram thorax normal
Clinical narrative: Patient is a 71 y.o. female patient of MD with lymphoma, breast cancer with known metastasis to lung and bone presented to Hospital from ER with A-fib with RVR and positive COVID.   New onset A-fib with RVR In the setting of COVID infection Heart rate was 126 on admission, now converted to sinus rhythm Continue Coreg, uptitrate as blood pressure and heart rate tolerate TSH within normal limits Echo pending Cardiology to see outpatient Started on Eliquis this hospitalization     Covid-19 Virus Infection Date of onset of symptoms: 9/27/2023 Symptoms present on admission: Yes Date of covid positive test: 9/28/2023 Vaccination status: vaccinated 1 dose Imaging: CT Oxygen requirements on admission: Yes Current oxygen requirements: 2 L, baseline Medical therapy: remdesivir, steroids Consultants following: ID Anticipated special isolation end date: 10/7/2023 We will see if would be eligible for Paxlovid with ID Discontinue azithromycin and ceftriaxone given no increased oxygen requirements or consolidation on CT chest Continue steroids on discharge Lymphoma Breast cancer, metastatic With metastasis to lung and bone Consult oncology, recommendations appreciated Per oncology hold acalabrutinib and abemaciclib while admitted with acute illness given potential for myelosuppression in the setting of active infection with COVID-19 Continue home letrozole Patient to follow-up outpatient with her primary oncologist before resuming   Chronic oxygen use 2/2 breast cancer metastasis Home oxygen 2 L
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, SARS-CoV-2 test positive, Sinus rhythm
Clinical narrative: Patient is a 71 y.o. female patient of MD with lymphoma, breast cancer with known metastasis to lung and bone presented to Hospital from ER with A-fib with RVR and positive COVID.   New onset A-fib with RVR In the setting of COVID infection Heart rate was 126 on admission, now converted to sinus rhythm Continue Coreg, uptitrate as blood pressure and heart rate tolerate TSH within normal limits Echo pending Cardiology to see outpatient Started on Eliquis this hospitalization     Covid-19 Virus Infection Date of onset of symptoms: 9/27/2023 Symptoms present on admission: Yes Date of covid positive test: 9/28/2023 Vaccination status: vaccinated 1 dose Imaging: CT Oxygen requirements on admission: Yes Current oxygen requirements: 2 L, baseline Medical therapy: remdesivir, steroids Consultants following: ID Anticipated special isolation end date: 10/7/2023 We will see if would be eligible for Paxlovid with ID Discontinue azithromycin and ceftriaxone given no increased oxygen requirements or consolidation on CT chest Continue steroids on discharge Lymphoma Breast cancer, metastatic With metastasis to lung and bone Consult oncology, recommendations appreciated Per oncology hold acalabrutinib and abemaciclib while admitted with acute illness given potential for myelosuppression in the setting of active infection with COVID-19 Continue home letrozole Patient to follow-up outpatient with her primary oncologist before resuming   Chronic oxygen use 2/2 breast cancer metastasis Home oxygen 2 L
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: The patient received doses 1-3 of the Pfizer 6mo-4 yr monovalent COVID vaccine on 6/29/22, 8/1/22. and 9/26/22 respectively.  When the bivalent dose came out the patient received a dose of the  Pfizer 6mo-4 yr bivalent COVID vaccine on 9/6/23, despite the fact that she had turned 5 on 3/14/2023.  It was our understanding per the recommendations  that if the patient started with the 6mo-4 yr vaccine, they should finish the series with that despite turning 5, however we did not realize that the series was considered "complete" with the 3 monovalent doses.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: LOCALIZED SWELLING IN SHOULDER AREA TO A BIT LARGER THAN QUARTER (PER PT, QUARTER SIZED)
Age: 30.0
Sex: F
Vaccine: FLU4
Symptoms: Dysphonia, Hypersensitivity, Oral discomfort, Sensation of foreign body
Clinical narrative: Flu Vaccine: case resulting in allergic reaction Patient received Afluria Quadrivalent Influenze Vaccine on 10/7/23. Pt admitted to ED with possible allergic reaction after receiving seasonal flu vaccine. Pt reports experiencing symptoms such as burning sensation on the roof of her mouth and feeling a lump in her throat with a slightly hoarse voice. She denied any difficulty swallowing, shortness of breath or trouble breathing. She reported no tongue/lip swelling nor intraoral/throat swelling. Patient denied nausea, vomiting, and diarrhea. She experienced no rashes, and does not have a history of reaction to the flu vaccine. Pt recieved children's benadryl. No harm came to patient.